About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Garetosmab
- Company
- Regeneron Pharmaceuticals
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 2 recruiting
Efficacy results: Not yet reported
2 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Nov 19, 2026
Find a Clinical Trial Near Me
See recruiting studies for Garetosmab and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT02745158
The Fibrodysplasia Ossificans Progressiva (FOP) Registry
The International FOP Association 800 participants Est. completion 2040-12-31 1 siteOther conditions: Fibrodysplasia Ossificans Progressiva (FOP)View official trial listing → -
Recruiting NCT NCT04479072
Aspirin and Preeclampsia
Not yet reported University of Chicago 180 participants Est. completion 2026-12-31 1 siteOther conditions: Preeclampsia PostpartumView official trial listing → -
Completed NCT NCT01589016
Activin A and Inhibin A in Predicting Outcome of Pregnancies of Unknown Location After Assisted Reproductive Technology
Instituto Valenciano de Infertilidad, IVI VALENCIA 96 participants Est. completion 2012-07 1 siteOther conditions: Ectopic PregnanciesView official trial listing → -
Completed NCT NCT01604642
Role of Activin A (ActA) in the Human Cancer Cachexia
Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 150 participants Est. completion 2016-01-01 1 siteOther conditions: Colorectal Cancer, Lung CancerView official trial listing → -
Completed NCT NCT02019095
Clinical and Biological Markers in Acute Respiratory Failure
University of Athens 55 participants Est. completion 2014-12 2 sitesOther conditions: Ventilator-Associated Pneumonia, Acute Respiratory Distress SyndromeView official trial listing → -
Withdrawn NCT NCT02328742
Development of a Bioabsorbable Medical Device for the Prevention of Postoperative Intra-uterine Adhesions.
Centre Hospitalier Universitaire de Nīmes Est. completion 2018-05 3 sitesOther conditions: Infertility, Abortion, Spontaneous, Embryo Implantation, DelayedView official trial listing → -
Completed NCT NCT02870400
A Study to Examine the Safety and Tolerability of Single Ascending Doses of REGN2477
Not yet reported Regeneron Pharmaceuticals 41 participants Est. completion 2017-01-12 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT02943239
Study of Safety, Tolerability, and Pharmacokinetics of REGN2477 Alone and in Combination With REGN1033 in Healthy Postmenopausal Women and Healthy Adult Men
Not yet reported Regeneron Pharmaceuticals 82 participants Est. completion 2019-04-30 2 sites Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT03162042
Role of Myostatin, Activin A and Follistatin Cachexia of ENT Cancers
University Hospital, Clermont-Ferrand 60 participants Est. completion 2017-05 1 siteOther conditions: Cachexia, Squamous Cell Carcinoma, Head and Neck CancerView official trial listing → -
Completed NCT NCT03188666
A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva
Not yet reported Regeneron Pharmaceuticals 44 participants Est. completion 2021-09-16 11 sites Stand-aloneOther conditions: Fibrodysplasia Ossificans ProgressivaView official trial listing → -
Withdrawn NCT NCT03710941
Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis
Not yet reported Regeneron Pharmaceuticals Est. completion 2020-11-05 Stand-aloneOther conditions: Sporadic Inclusion Body MyositisView official trial listing → -
Status unknown NCT NCT04489251
Assessment of the TGF-beta Pathway and Micro-RNA in Pediatric Pulmonary Arterial Hypertension
Medical College of Wisconsin 40 participants Est. completion 2023-01-01 1 siteOther conditions: Pulmonary Arterial HypertensionView official trial listing → -
Completed NCT NCT04525404
MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected Patients
University of Alberta 215 participants Est. completion 2022-09-30 2 sitesOther conditions: Covid19, Coronavirus Infection, SARS-CoV InfectionView official trial listing → -
Withdrawn NCT NCT04577820
Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)
Not yet reported Regeneron Pharmaceuticals Est. completion 2022-10-08 Stand-aloneOther conditions: Fibrodyplasia Ossificans Progressiva (FOP), Heterotopic Ossification (HO)View official trial listing → -
Active, not recruiting NCT NCT05394116
A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)
Not yet reported Regeneron Pharmaceuticals 63 participants Est. completion 2029-02-27 22 sites Stand-aloneOther conditions: Fibrodysplasia Ossificans ProgressivaView official trial listing → -
Active, not recruiting NCT NCT05534932
Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women
Not yet reported University of Chicago 20 participants Est. completion 2026-11-01 1 siteOther conditions: Preeclampsia PostpartumView official trial listing → -
Status unknown NCT NCT05794737
Immunohistochemical Expression of Inhibin Beta A (INHBA) in Colorectal Carcinoma
Sohag University 60 participants Est. completion 2024-06-30 1 siteOther conditions: Colorectal CancerView official trial listing → -
Completed NCT NCT06064656
A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossificans Progressiva (FOP)
Regeneron Pharmaceuticals 131 participants Est. completion 2023-09-29 1 siteOther conditions: Fibrodysplasia Ossificans Progressiva (FOP)View official trial listing → -
Completed NCT NCT06110221
Activin-A and Interleukin-1β Levels in Periodontitis
Aydin Adnan Menderes University 75 participants Est. completion 2020-02-02 1 siteOther conditions: Periodontitis, Gingivitis, Periodontal HealthView official trial listing → -
Not yet recruiting NCT NCT06188533
Urinary Activin A as Apredictive Marker for Assessement of Acute Kidney Injury Severity in Patient Admitted at Assuit University Hospital
Assiut University 70 participants Est. completion 2026-12-05Other conditions: Urinary Activin A in AKIView official trial listing → -
Completed NCT NCT06299098
A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation
Not yet reported Regeneron Pharmaceuticals 1005 participants Est. completion 2026-10-21 60 sites Added to GLP-1Other conditions: ObesityView official trial listing → -
Active, not recruiting NCT NCT06508021
A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)
Not yet reported, Not yet reported Ashibio Inc 92 participants Est. completion 2029-02-04 3 sitesOther conditions: Fibrodysplasia Ossificans ProgressivaView official trial listing → -
Withdrawn NCT NCT06970405
Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal Women
Not yet reported Regeneron Pharmaceuticals Est. completion 2026-06-08 Stand-aloneOther conditions: ObesityView official trial listing → -
Active, not recruiting NCT NCT07253363
Circulating Activin-A and FSTL3 in Precapillary Pulmonary Hypertension
Not yet reported Assistance Publique - Hôpitaux de Paris 550 participants Est. completion 2028-04 1 siteOther conditions: Pulmonary HypertensionView official trial listing → -
Approved For Marketing NCT NCT07301450
An Expanded Access Program of Garetosmab in Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)
Regeneron PharmaceuticalsOther conditions: Fibrodysplasia Ossificans Progressiva (FOP)View official trial listing → -
Not yet recruiting NCT NCT07559513
A Study to Investigate the Safety, Pharmacokinetics (PK), and Efficacy of Garetosmab in Children and Adolescents With Fibrodysplasia Ossificans Progressiva (FOP)
Not yet reported Regeneron Pharmaceuticals 18 participants Est. completion 2030-07-08 Stand-aloneOther conditions: Fibrodysplasia Ossificans Progressiva, FOPView official trial listing → -
Completed NCT NCT07637435
Role of Vascular Endothelial Markers in Predicting Renal Prognosis and Mortality in Patients Undergoing HD-AKI
Not yet reported Muğla Sıtkı Koçman University 170 participants Est. completion 2025-12-15 1 siteOther conditions: Acute Kidney Injury, HemodialysisView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Garetosmab, Pasatru, REGN2477, Activin A
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
